Department of Drug Sciences, University of Pavia, 27100 Pavia, Italy.
Department of Drug Sciences, University of Pavia, 27100 Pavia, Italy; Pharmaexceed srl, 27100 Pavia, Italy.
Int J Biol Macromol. 2018 Oct 15;118(Pt A):792-799. doi: 10.1016/j.ijbiomac.2018.06.135. Epub 2018 Jun 27.
Intervertebral disk degeneration is an oxidative and inflammatory pathological condition that induces viability and functionality reduction of Nucleus Pulposus cells (NPs). Cellular therapies were previously proposed to repair and substitute the herniated disk but low proliferative index and pathological conditions of NPs dramatically reduced the efficacy of this approach. To overcome these problems we proposed, for the first time, a therapeutic system based on the association of silk sericin microparticles and platelet-derived products. Silk sericin (SS) is a bioactive protein with marked antioxidant properties, while platelet lysate (PL) and platelet poor plasma (PPP) represent a source of growth factors able to support cell viability and to promote tissue regeneration. We demonstrated that the mixture PL + PPP promoted NPs proliferation with a significant reduction of cellular doubling time. SS microparticles, alone or in combination with PPP, presented the higher ROS-scavenging activity while, SS microparticles and PL resulted as the best association able to protect NPs against oxidative stress induce by hydroxide peroxide. Based on these results, the authors are confident that, with the ever increasing need of efficacious tools for regenerative medicine purposes, SS microparticles and PL + PPP association could represent an effective approach for the development of low impact and non-invasive therapies.
椎间盘退变是一种氧化和炎症性病理状况,会降低髓核细胞(NPs)的活力和功能。细胞疗法先前被提议用于修复和替代椎间盘突出,但 NPs 的低增殖指数和病理状况极大地降低了这种方法的效果。为了克服这些问题,我们首次提出了一种基于丝胶微颗粒和血小板衍生产品联合的治疗系统。丝胶(SS)是一种具有显著抗氧化特性的生物活性蛋白,而血小板裂解液(PL)和贫血小板血浆(PPP)则是能够支持细胞活力和促进组织再生的生长因子的来源。我们证明了 PL+PPP 的混合物可促进 NPs 的增殖,同时显著降低细胞倍增时间。SS 微颗粒单独或与 PPP 联合使用时,具有最高的 ROS 清除活性,而 SS 微颗粒和 PL 则是能够保护 NPs 免受由过氧化物引起的氧化应激的最佳组合。基于这些结果,作者相信,随着对再生医学有效工具的需求不断增加,SS 微颗粒和 PL+PPP 联合可能是开发低影响和非侵入性治疗方法的有效途径。